This is a recording of a session from AMP Europe 2021 Virtual Meeting. Purchase a bundle of 8 sessions from the AMP Europe 2021 Virtual Conference for a significant discount by clicking this link.
Session Description:
While biobanking samples for research studies has been a long-standing resources at many institutions, these have not been focused on doing this at a national scale nor with an eye toward clinical impact. Many European nations have taken a lead role in demonstrating the benefits and challenges of implementing large population studies within a national cohort and with a specific focus in genomics. In this session we will hear from some of the population studies at the forefront of implementing genomic medicine within a national infrastructure.
Objectives:
After this session, participants will be able to:
- Understand the technical and logistical considerations when implementing a population level genomic study
- Examine how genetic risk information augments and modifies the effects of the traditional risk factors
- Evaluate the approaches and outcomes when providing genetic risk information
Chair: Dr. Matthew Lebo
Presentations:
- Genetic and Clinical Risk of Common Complex Diseases in FinnGen Study, Dr. Samuli Ripatti
-
Return of Data Activities in Population-based Biobank: Current Experience and Implications for Personalized Prevention on a National Scale, Dr. Neeme Tõnisson
Duration: 92 minutes
Recording Date: June 15, 2021
Last day to purchase: December 31, 2024
There are no CME or CMLE credits available.Note: Join the AMP Family for discounted access to the most current educational resources!
All sales are final. No refunds will be issued.
No digital files may be reproduced or transmitted in any form, by any means, electronic or mechanical. By purchasing a product, you agree to not share any of the course materials, including videos, downloadable slide presentations, outlines, manuscripts, etc. without explicit and written permission from AMP.
